Highlights and Quick Summary
- Income after Tax for the quarter ending February 28, 2022 was $-3.18 Million (a 206.38% increase compared to previous quarter)
- Year-over-year quarterly Income after Tax decreased by -0.46%
- Annual Income after Tax for 2021 was $-103 Million (a 1.78% increase from previous year)
- Annual Income after Tax for 2020 was $-101 Million (a 1312.87% increase from previous year)
- Annual Income after Tax for 2019 was $-7.17 Million (a -141.38% decrease from previous year)
- Twelve month Income after Tax ending February 28, 2022 was $-29.1 Million (a -62.66% decrease compared to previous quarter)
- Twelve month trailing Income after Tax decreased by -74.1% year-over-year
Trailing Income after Tax for the last four month:
28 Feb '22 | 30 Nov '21 | 31 Aug '21 | 31 May '21 |
---|---|---|---|
$-29.1 Million | $-78 Million | $-103 Million | $-113 Million |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Income after Tax of Organigram Holdings Inc.
Most recent Income after Taxof OGI including historical data for past 10 years.Interactive Chart of Income after Tax of Organigram Holdings Inc.
Organigram Holdings Inc. Income after Tax for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $-3.18 | – | – | – | – |
2021 | $-1.04 | $-21.72 | $-3.2 | $-52.09 | $-103.09 |
2020 | $-26.08 | $-31.14 | $-64.31 | $-5.19 | $-101.29 |
2019 | $-0.65 | $-17.34 | $-7.59 | $-4.79 | $-7.17 |
2018 | $22.56 | $2.52 | – | – | $17.33 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic